Public health impact and cost-effectiveness of catch-up 9-valent HPV vaccination of individuals through age 45 years in the United States

• Hoofdauteurs: Vincent Daniels (Auteur), Vimalanand S. Prabhu (Auteur), Cody Palmer (Auteur), Salome Samant (Auteur), Smita Kothari (Auteur), Craig Roberts (Auteur), Elamin Elbasha (Auteur)
• Formaat: Boek
• Gepubliceerd in: Taylor & Francis Group, 2021-07-01T00:00:00Z.
• Onderwerpen: article
• Online toegang: Connect to this object online.

The Advisory Committee on Immunization Practices (ACIP) recommended catch-up 9-valent Human Papillomavirus (HPV) vaccination through age 26 years, and shared clinical decision-making for adults aged 27-45 years, compared with catch-up through age 26 years and 21 years for females and males, respecti...